Healthcare Industry and Market Outlook in Vietnam

Vietnam's healthcare system is built around a large public hospital network, coordinated by the Ministry of Health, with financing increasingly channelled through Vietnam Social Security's national health-insurance scheme, which covers a large and growing share of the population. Public hospitals particularly major tertiary centres in Hanoi and Ho Chi Minh City handle high patient volumes and are frequently the first point of access even for patients who could afford private alternatives.

Private healthcare is a smaller but fast-growing segment, concentrated in the largest cities, where private hospitals and clinics are expanding to serve a rising middle class willing to pay for shorter wait times, higher service standards, or specialist access not readily available in crowded public facilities.

Demand growth reflects both rising household healthcare spending and a shifting disease burden from a historical focus on infectious disease and maternal-child health toward increasing chronic-disease management, driven by an aging population and rising rates of conditions such as diabetes and cardiovascular disease.

Market entry generally requires working with the Ministry of Health for licensing and registration, alongside an understanding of Vietnam Social Security's insurance and reimbursement framework, since a large share of hospital revenue and patient volume flows through public insurance channels even where private providers are involved.

Healthcare facilities, pharmaceuticals and medical devices are regulated primarily through the Ministry of Health under the Law on Medical Examination and Treatment, which introduced a service-capability-based facility licensing model and a national competency examination for clinical practice licensing. Foreign entrants typically need local partners to navigate drug and device registration pathways.

Vietnam Social Security's health-insurance framework (Social Health Insurance, or BHYT) governs a large share of reimbursement and procurement decisions, making it a central consideration for any provider, pharmaceutical or device strategy. Healthcare remains a specially encouraged investment sector, with 100% foreign ownership permitted in healthcare facilities.

Foreign-investment conditions, licensing timelines and reimbursement rules can change and vary by facility type and locality specific requirements should be validated directly with the relevant Vietnamese authority before market-entry decisions.